R&D Changing Faces: Pharma and biotech hires – February 2025 February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number of changes at the big pharmas, which may have slipped under you
Sales & Marketing Changing Faces: Pharma and biotech January 2025 Welcome to the first edition of Changing Faces for 2025.
News Lawrence Tallon will lead MHRA after June Raine retires Lawrence Tallon has been named head of the MHRA, effective 1st April, replacing Dame June Raine who is retiring.
News Indivior changes CEO after warning sales will fall in 2025 UK-listed pharma company Indivior has appointed pharma veteran Joe Ciaffoni as its new chief executive, replacing Mark Crossley.
News Ex-CDER chief Cavazzoni rejoins Pfizer as CMO In a move that will raise eyebrows in Washington, Pfizer has hired former FDA director Patricia Cavazzoni as its new chief medical officer.
News RFK Jr-led commission will assess 'threats' to children New HHS Secretary RFK Fr has been given the task of investigating child health in the US, including whether some medicines may pose a threat.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.